Definium Therapeutics
Entity.
- Evidence
- 29 documents · 8 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 12 Aug 2026, last seen 30 Sept 2026
- Measured
- 17% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- SEC · 2026-09-30 · 4 - Definium Therapeutics, Inc. (0001813814) (Issuer) (opens the source in a new tab)
- SEC · 2026-09-30 · 4 - Wiley Matthew T. (0001759703) (Reporting) (opens the source in a new tab)
- SEC · 2026-09-30 · 4 - Sullivan Mark (0001331843) (Reporting) (opens the source in a new tab)
- SEC · 2026-09-30 · 4 - Karlin Daniel (0001897618) (Reporting) (opens the source in a new tab)
- SEC · 2026-09-30 · 4 - Barrow Robert (0001897557) (Reporting) (opens the source in a new tab)
- Psychedelic Alpha · 2026-09-25 · Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike (opens the source in a new tab)
- Psychedelic Alpha · 2026-09-22 · Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers (opens the source in a new tab)
- SEC · 2026-09-19 · 4 - Vallone Carol A (0001422058) (Reporting) (opens the source in a new tab)
- SEC · 2026-09-19 · 4 - Krebs Andreas (0001438946) (Reporting) (opens the source in a new tab)
- SEC · 2026-09-14 · 8-K - Definium Therapeutics, Inc. (0001813814) (Filer) (opens the source in a new tab)
- SEC EDGAR · 2026-09-08 · 8-K - Definium Therapeutics, Inc. (0001813814) (Filer) [Other Events] (opens the source in a new tab)
- SEC EDGAR · 2026-08-12 · 8-K - Definium Therapeutics, Inc. (0001813814) (Filer) [Reg FD Disclosure, Other Events] (opens the source in a new tab)